Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,7413,760 of 20,252 grants

Active NON-SBIR/STTR RPGS
Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2026

Project Summary Despite the progress made in precision oncology, clinicians typically face a vast volume and variety of next- generation sequencing and molecular data that is frequ...

$3.87M
USD
Active OTHER RESEARCH-RELATED
Harnessing the repetitive genome for cancer immunotherapy
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARYThis KOS proposal describes a five-year career development training program in cancer epigenetics and tumor immunology. Dr. Gabriel Griffin has completed clinical tr...

$2.69M
USD
Active NON-SBIR/STTR RPGS
Early response to radiotherapy and immunotherapy in rectal cancer: an integrated molecular, cellular, and spatial approach
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Project Abstract With increased incidence in young populations and ~65% three-year survival of high-risk locally advanced rec- tal cancer, innovative approaches to improve outcomes...

$6.24M
USD
Active NON-SBIR/STTR RPGS
A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches.
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2023 – 2026

PROJECT SUMMARY The tumor microenvironment (TME) in essentially all epithelial cancers is associated with significant biochemical and structural changes in the extracellular matrix...

$1.98M
USD
Active NON-SBIR/STTR RPGS
Enhancing TET activity for the treatment of hematological malignancy
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2028

PROJECT SUMMARY Advanced age in the majority of acute myeloid leukemia (AML) patients limits the use of aggressive chemotherapy leading to poor overall survival. Alternative treatm...

$3.34M
USD
Active NON-SBIR/STTR RPGS
Tumor-intrinsic and paracrine roles of endoglin in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Arizona United States 2023 – 2028

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy featuring early metastasis, late onset of symptoms, and notorious resistance to existing therapies. A critic...

$3.57M
USD
Active NON-SBIR/STTR RPGS
Label-free imaging of CAR T cell metabolism
NATIONAL CANCER INSTITUTE Morgridge Institute for Research, Inc United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT The goal of this proposal is to develop non-invasive single-cell technologies to improve the potency of T cell therapies against cancer. The first 6 chim...

$6.16M
USD
Completed NON-SBIR/STTR RPGS
A Pilot Feasibility Study of an Intervention to Decrease Overtreatment of Low-risk Thyroid Cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2025

PROJECT SUMMARY Nearly 90% of patients with low-risk papillary thyroid cancer undergo total thyroidectomy, the treatment option with the greatest morbidity, even though less invasi...

$840.2K
USD
Active NON-SBIR/STTR RPGS
Vascular regulation of fatty acid transport in metastatic tumor outgrowth
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2023 – 2028

Project Summary Tumor metastasis requires supportive microenvironment for outgrowth of disseminated tumor cells. The switch of metastatic cells from dormant to proliferative state...

$4.8M
USD
Active NON-SBIR/STTR RPGS
Optimizing Treatment of Prostate Cancer in Men living with HIV
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2023 – 2028

SUMMARY Cancer is a leading cause of morbidity and mortality among aging people with HIV (PWH) and prostate cancer is now one of the most common cancers among PWH. Despite this, pr...

$6.69M
USD
Active NON-SBIR/STTR RPGS
Consequences of retrotransposition on genome integrity
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

Project SummaryTransposable elements are a major source of human genetic variation and also contribute to human diseases by causing somatic mutations. The activity of transposition...

$7.02M
USD
Active NON-SBIR/STTR RPGS
HIGHLY SELECTIVE MACROBIOMOLECULAR ISOLATION, SOFT-LANDING AND CHARACTERIZATION USING STRUCTURES FOR LOSSLESS ION MANIPULATIONS
NATIONAL CANCER INSTITUTE Battelle Pacific Northwest Laboratories United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT (30 lines) This project aims to address the current gap in technology for rapid and comprehensive (mass, structure) profiling of biomacromolecules. While h...

$4.5M
USD
Active NON-SBIR/STTR RPGS
SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2027

Advances in cancer prevention, diagnosis, and treatment have dramatically improved long-term survival of those diagnosed with breast cancer. However, this success has been tempered...

$3M
USD
Completed NON-SBIR/STTR RPGS
Emerging role of tumor-derived exosomes in immune modulation and breast cancer health disparity.
NATIONAL CANCER INSTITUTE University of North Texas Hlth Sci Ctr United States 2023 – 2025

Project Abstract Triple-negative breast cancer (TNBC) is an aggressive and invasive breast cancer subtype, accounting for 10-15% of breast cancer diagnoses. TNBC affects African-Am...

$1.97M
USD
Active OTHER RESEARCH-RELATED
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT My long-term career goal is to improve outcomes for pediatric patients with acute myeloid leukemia (AML), in part through development of improved modalitie...

$2.28M
USD
Active NON-SBIR/STTR RPGS
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

Project Summary/Abstract Small-cell lung cancer (SCLC) kills over 30,000 Americans every year and has a dismal 5-year overall survival rate of less than 7%. However, SCLC outcomes...

$6.14M
USD
Active NON-SBIR/STTR RPGS
Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2028

Abstract Aggressive malignant progression and spreading has limited a clear understanding of the pathophysiology of SCLC. The overarching goal of this “bedside to bench” project is...

$4.02M
USD
Active NON-SBIR/STTR RPGS
Molecular mechanisms and therapeutic targeting of activated NRF2 signaling in MiT/TFE translocation renal cell carcinoma
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY Renal cell carcinoma (RCC) is one of the top ten most common cancers worldwide and is comprised of multiple distinct histologies. One particularly aggressive subtyp...

$5.09M
USD
Active NON-SBIR/STTR RPGS
Understanding and addressing rejection of personalized cancer risk information
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT We are entering an era of precision medicine for cancer screening in which screening initiation and maintenance is based on personal risk estimates that in...

$6.61M
USD
Active NON-SBIR/STTR RPGS
Advanced Sample Preparation, Separation and Multiplexed Analysis for In-Depth Proteome Profiling of >1000 Single Cells Per Day
NATIONAL CANCER INSTITUTE Brigham Young University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Cancer tissues exhibit a high degree of phenotypic heterogeneity and plasticity and contain numerous subpopulations of cells in various states. Quantifying...

$5.3M
USD